Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olsalazine Sodium Capsules

Approval Number

国药准字H20010061

Company浙江华润三九众益制药有限公司

Registration Date

June 12, 2020

Drug Information

Generic Name

奥沙拉秦钠胶囊

Trade Name

帕斯坦

Brand Name

帕斯坦

Dosage Form

胶囊剂

Strength

0.25g

Drug Type

化学药品

Registration Date

June 12, 2020

Company Information

Applicant Company

Company Name浙江华润三九众益制药有限公司

Company Address

浙江省丽水市水阁工业区绿谷大道279号

Manufacturing Company

Company Name浙江华润三九众益制药有限公司

Company Address

浙江省丽水市水阁工业区绿谷大道279号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy